Now more than ever, collaboration in research is key. “These days, the best and most impactful discoveries are made by teams of scientists,” said Linden Hu, vice dean of research at the School of Medicine. Recognition of that principle is guiding the medical school—and all of Tufts University—into the future. “Everyone realizes that scientists and scholars can’t work in isolation anymore,” said Simin Meydani, Tufts vice provost for research. “Given the nature of problems faculty need to address today, it’s a lot more efficient to utilize each other’s strengths and build synergy, rather than try to do everything by yourself.”
The newly launched Center for Integrated Management of Antimicrobial Resistance (CIMAR) and the Tufts Clinical and Translational Science Institute (CTSI)—which recently received a $56 million award from the National Institutes of Health—are just two of the exciting initiatives that embody Tufts’ commitment to enhancing multi-disciplinary collaboration. Each brings together investigators and clinicians from across the medical school, the university, and Tufts Medical Center to solve pressing real-world problems with a One Health approach. “Both of these are attempts to move translational projects more quickly from bench to bedside,” Hu said. In the pages ahead, learn how Tufts CTSI and CIMAR are doing just that.